Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 KATP channels
William A. Chutkow, … , Charles F. Burant, Elizabeth M. McNally
William A. Chutkow, … , Charles F. Burant, Elizabeth M. McNally
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):203-208. https://doi.org/10.1172/JCI15672.
View: Text | PDF
Article Aging

Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 KATP channels

  • Text
  • PDF
Abstract

Research Article

Authors

William A. Chutkow, Jielin Pu, Matthew T. Wheeler, Tomoyuki Wada, Jonathan C. Makielski, Charles F. Burant, Elizabeth M. McNally

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Cardiovascular physiology in Sur2–/– mice. (a) Sur2–/– mice exhibit decr...
Cardiovascular physiology in Sur2–/– mice. (a) Sur2–/– mice exhibit decreased survival. Survival of littermate control and heterozygous mice (Sur2+/+n = 15, 5 males and 10 females, and Sur2+/–, n = 41, 12 males and 29 females), homozygous mutant females (Sur2–/–, n = 18), and homozygous mutant males (Sur2–/–, n = 17) as a function of age. (b) Telemetric blood pressure recordings of Sur2–/– and normal littermate control mice. Representative blood pressure tracings from conscious, untethered control (Sur2+/+) and homozygous mutant (Sur2–/–) mice. (c) Systolic (white bars), diastolic (gray bars), and MAP (black bars) for littermate control and mutant mice (n = 6 and 4, respectively), recorded between days 2 and 4 after implantation. *P < 0.04, **P < 0.03, ***P < 0.02 versus normal littermate controls by two-tailed, unpaired Student t test. (d) Sur2–/– mice do not respond to KATP vasoactive agents. Representative MAP tracings from a littermate control mouse (dotted line) and a Sur2–/– mouse (solid line) during infusions of the agents indicated. Pinacidil was administered at 5 μg/kg/min and glibenclamide at 100 μg/kg/min. The interrupted line for glyburide infusion indicates the beginning of infusion for the normal control mouse (Sur2+/+), while the mutant mouse (Sur2–/–) infusion begins with the solid line.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts